Priyanka Sharma

13.2k total citations
131 papers, 1.8k citations indexed

About

Priyanka Sharma is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Priyanka Sharma has authored 131 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 56 papers in Cancer Research and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Priyanka Sharma's work include Breast Cancer Treatment Studies (42 papers), Advanced Breast Cancer Therapies (31 papers) and Cancer Treatment and Pharmacology (24 papers). Priyanka Sharma is often cited by papers focused on Breast Cancer Treatment Studies (42 papers), Advanced Breast Cancer Therapies (31 papers) and Cancer Treatment and Pharmacology (24 papers). Priyanka Sharma collaborates with scholars based in United States, India and Germany. Priyanka Sharma's co-authors include Qamar J. Khan, Anne O’Dea, Bruce F. Kimler, Carol J. Fabian, Jennifer R. Klemp, Andrew K. Godwin, Shane R. Stecklein, Pavan S. Reddy, Rachel Yoder and Jamie L. Wagner and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Priyanka Sharma

117 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Priyanka Sharma United States	22	1.1k	692	557	406	335	131	1.8k
Ignasi Tusquets Spain	23	970 0.9×	627 0.9×	608 1.1×	219 0.5×	448 1.3×	73	1.9k
Laura García‐Estévez Spain	20	1.1k 1.0×	649 0.9×	438 0.8×	506 1.2×	201 0.6×	68	1.7k
Yanyuan Wu United States	25	987 0.9×	635 0.9×	1.3k 2.3×	314 0.8×	221 0.7×	64	2.3k
Abdelbaset Buhmeida Saudi Arabia	27	795 0.7×	523 0.8×	802 1.4×	261 0.6×	185 0.6×	101	2.0k
Georg Pfeiler Austria	24	952 0.9×	527 0.8×	532 1.0×	286 0.7×	389 1.2×	91	1.7k
Mangesh A. Thorat United Kingdom	19	690 0.6×	559 0.8×	701 1.3×	341 0.8×	304 0.9×	54	1.7k
Zhenzhou Shen China	20	689 0.6×	574 0.8×	551 1.0×	202 0.5×	204 0.6×	54	1.5k
Laura Pizzuti Italy	23	906 0.8×	410 0.6×	454 0.8×	333 0.8×	160 0.5×	96	1.7k
Xichun Hu China	28	1.3k 1.3×	715 1.0×	1.2k 2.1×	770 1.9×	191 0.6×	155	2.8k
Jieqiong Liu China	23	801 0.7×	543 0.8×	504 0.9×	313 0.8×	112 0.3×	73	1.6k

Countries citing papers authored by Priyanka Sharma

Since Specialization

Citations

This map shows the geographic impact of Priyanka Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priyanka Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priyanka Sharma more than expected).

Fields of papers citing papers by Priyanka Sharma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priyanka Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priyanka Sharma. The network helps show where Priyanka Sharma may publish in the future.

Co-authorship network of co-authors of Priyanka Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Priyanka Sharma. A scholar is included among the top collaborators of Priyanka Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priyanka Sharma. Priyanka Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balogh, Erin P., Laura A. Levit, Joseph M. Unger, et al.. (2025). ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States. JCO Oncology Practice. 21(12). 1746–1758.

Sammons, Sarah, DA Yardley, Priyanka Sharma, et al.. (2025). Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2− Advanced Breast Cancer. Oncology and Therapy. 14(1). 19–25.

Sharma, Priyanka, et al.. (2025). Bridging smiles: AI-driven dental health awareness for the next gen—a systematic review. Frontiers in Dental Medicine. 6. 1639572–1639572.

Sharma, Nisha, Yogesh K. Ahlawat, Priyanka Sharma, et al.. (2025). Nano-films as a sustainable, biopolymer-based solution for post-harvest losses and improved shelf life of horticultural crops: a comprehensive review. Journal of Coatings Technology and Research. 23(1). 55–75. 3 indexed citations

Sharma, Priyanka, et al.. (2024). A CFD simulation analysis of the effects of PCM and nanoparticles stored in copper cylinders inside a solar still. Journal of Energy Storage. 108. 115091–115091. 11 indexed citations

Abdou, Yara, Prarthna V Bhardwaj, Rachel O. Abelman, et al.. (2024). Abstract PO3-05-14: Practice patterns for sequential use of antibody-drug conjugate after antibody-drug conjugate in metastatic breast cancer: results from a physician survey. Cancer Research. 84(9_Supplement). PO3–5. 1 indexed citations

Kalinsky, Kevin, William E. Barlow, Harsh B. Pathak, et al.. (2024). Correlation of serum anti-Müllerian hormone (AMH) levels on identification of premenopausal patients (pts) with hormone receptor positive (HR+), HER2-negative, node-positive breast cancer most likely to benefit from adjuvant chemotherapy in SWOG S1007 (RxPONDER).. Journal of Clinical Oncology. 42(16_suppl). 505–505. 5 indexed citations

Jeselsohn, Rinath, Jingxin Fu, Reshma Mahtani, et al.. (2024). Abstract PS12-02: Exploration of ctDNA Dynamics in the PACE Trial: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for HR+/HER2- Metastatic Breast Cancer. Cancer Research. 84(9_Supplement). PS12–2. 1 indexed citations

Bardia, Aditya, Lajos Pusztai, Kathy S. Albain, et al.. (2024). TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy. Therapeutic Advances in Medical Oncology. 16. 12693072–12693072. 16 indexed citations

10.

Stecklein, Shane R., Roberto Salgado, Anne O’Dea, et al.. (2024). NeoTRACT: Phase II trial of neoadjuvant tumor infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 42(16_suppl). TPS629–TPS629. 3 indexed citations

11.

Sharma, Priyanka, et al.. (2024). Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights. Medical Oncology. 41(2). 45–45. 5 indexed citations

12.

Sharma, Priyanka, et al.. (2024). A comprehensive review of the molecular mechanisms driving skin photoaging and the recent advances in therapeutic interventions involving natural polyphenols. South African Journal of Botany. 166. 466–482. 12 indexed citations

13.

Sharma, Priyanka, et al.. (2024). Exploring the Idea of Human Reproduction in Space: A Potential Area for Future Research. Cureus. 16(11). e73712–e73712. 1 indexed citations

14.

Larson, Kelsey E., Christa Balanoff, Lauren Nye, et al.. (2023). Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy. Healthcare. 11(3). 417–417. 4 indexed citations

15.

Stecklein, Shane R., Devin C. Koestler, Nanda Kumar Yellapu, et al.. (2023). Extracellular vesicle-derived non-coding RNAs to predict outcome in patients with triple-negative breast cancer (TNBC) with residual disease (RD).. Journal of Clinical Oncology. 41(16_suppl). 578–578. 3 indexed citations

16.

Sharma, Priyanka, Shane R. Stecklein, Rachel Yoder, et al.. (2023). Abstract PD11-07: PD11-07 Association of TNBC-DX scores with outcomes in triple-negative breast cancer (TNBC) treated with neoadjuvant pembrolizumab and chemotherapy: a correlative analysis from NeoPACT and NeoSTOP trials. Cancer Research. 83(5_Supplement). PD11–7. 2 indexed citations

17.

Spring, Laura M., William E. Barlow, Aditya Bardia, et al.. (2023). Abstract HER2-19: HER2-19 Impact of HER2 low status on clinical outcomes in participants with 1-3 positive lymph nodes, HR+/HER2- breast cancer with recurrence score </25 randomized to endocrine therapy +/- chemotherapy: results from SWOG S1007 (RxPONDER). Cancer Research. 83(5_Supplement). HER2–19. 1 indexed citations

18.

Jagsi, Reshma, William E. Barlow, Wendy A. Woodward, et al.. (2023). Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial. JAMA Oncology. 9(8). 1083–1083. 6 indexed citations

19.

Sharma, Priyanka, et al.. (2023). Histopathological Evaluation of Granulomatous Skin Lesions: A Study from North India. 17(2). 7–13.

20.

Griffiths, Jason I., Jinfeng Chen, Patrick A. Cosgrove, et al.. (2021). Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy. Nature Cancer. 2(6). 658–671. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact